Intravenous infusion of contaminated dextrose solution: The Deveonport incident.
D003352:Corynebacterium / Q000302:isolation & purification; D004340:Drug Contamination / Q000517:prevention & control; D004349:Drug Packaging / Q000592:standards; D004731:Endotoxins / Q000032:analysis; D004739:England; D004755:Enterobacteriaceae / Q000302:isolation & purification; D004864:Equipment and Supplies / Q000592:standards; D005947:Glucose / Q000008:administration & dosage / Q000009:adverse effects*; D006801:Humans; D007263:Infusions, Parenteral / Q000009:adverse effects*; D011183:Postoperative Complications / Q000382:microbiology; D011549:Pseudomonas / Q000302:isolation & purification; D012772:Shock, Septic / Q000209:etiology* / Q000382:microbiology / Q000401:mortality; D012996:Solutions; D013242:Sterilization
D004731:Endotoxins; D012996:Solutions; D005947:Glucose